Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-411324
Filing Date
2014-11-13
Accepted
2014-11-13 17:06:12
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d780647d10q.htm 10-Q 227509
2 EX-31.1 d780647dex311.htm EX-31.1 7477
3 EX-31.2 d780647dex312.htm EX-31.2 7440
4 EX-32.1 d780647dex321.htm EX-32.1 4771
5 EX-32.2 d780647dex322.htm EX-32.2 4721
  Complete submission text file 0001193125-14-411324.txt   2641766

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mnov-20140930.xml EX-101.INS 261982
7 XBRL TAXONOMY EXTENSION SCHEMA mnov-20140930.xsd EX-101.SCH 29301
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20140930_cal.xml EX-101.CAL 37689
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20140930_def.xml EX-101.DEF 183941
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20140930_lab.xml EX-101.LAB 265879
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20140930_pre.xml EX-101.PRE 213482
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 141219191
SIC: 2834 Pharmaceutical Preparations